Get the Stockscreener App
2.79
2.11%
-0.06
After Hours:
2.80
0.010
+0.36%
Goodrx Holdings Inc stock is traded at $2.79, with a volume of 1.68M.
It is down -2.11% in the last 24 hours and up +2.57% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$2.85
Open:
$2.85
24h Volume:
1.68M
Relative Volume:
0.55
Market Cap:
$947.02M
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-21.04
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
+2.95%
1M Performance:
+2.57%
6M Performance:
-42.36%
1Y Performance:
-34.81%
1-Day Range:
$2.76
$2.85
1-Week Range:
$2.72
$2.92
52-Week Range:
$2.61
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
2.79 | 967.38M | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
241.16 | 39.34B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 12.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
98.51 | 8.35B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
43.74 | 8.75B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
39.10 | 7.13B | 11.99B | 24.18M | 234.31M | 0.2956 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Underweight |
| Aug-11-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
How supply chain issues affect GoodRx Holdings Inc. stockEarnings Beat & AI Powered Market Entry Ideas - ulpravda.ru
Can GoodRx Holdings Inc. stock surprise with earnings upsideJuly 2025 Spike Watch & Target Return Focused Picks - ulpravda.ru
Why GoodRx Holdings Inc. stock could outperform in 2025Trade Exit Summary & Accurate Technical Buy Alerts - ulpravda.ru
Is GoodRx Holdings Inc. stock a safe buy before earningsForecast Cut & High Conviction Buy Zone Alerts - ulpravda.ru
Can GoodRx Holdings Inc. stock deliver strong Q4 earningsWeekly Volume Report & Expert Curated Trade Setup Alerts - ulpravda.ru
Scan a code at Giant Eagle to unlock cheaper Ozempic and Wegovy - Stock Titan
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring A 71.61% Upside Potential - DirectorsTalk Interviews
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost - Benzinga
GoodRx stock price target lowered to $2.60 at BofA on pharmacy headwinds - Investing.com UK
GoodRx Holdings Inc. (GDRX) PT Lowered to $2.60 at BofA Securities, Underperofrm, 'We Remain Cautious' - StreetInsider
New Wegovy weight-loss pill now $149 a month through GoodRx - Stock Titan
GoodRx stock price target lowered to $2.60 at BofA on pharmacy headwinds By Investing.com - Investing.com Nigeria
Preferred dividends of GoodRx Holdings, Inc. Class A – FWB:8GH - TradingView — Track All Markets
GoodRx Holdings And 2 Other Compelling Penny Stocks To Consider - Yahoo Finance
Morgan Stanley favors GoodRx (GDRX) and healthcare tech over managed care for 2026 citing strong market-beating potential - MSN
Morgan Stanley Favors GoodRx (GDRX) and Healthcare Tech Over Managed Care for 2026 Citing Strong Market-Beating Potential - Finviz
Aug Mood: Why GoodRx Holdings Inc. stock could outperform in 2025Trade Exit Report & Verified Chart Pattern Trade Signals - moha.gov.vn
Yakima Topic GOODRX HOLDINGS, INC. | News, Weather, Sports, Breaking News - KIMA
When Should You Buy GoodRx Holdings, Inc. (NASDAQ:GDRX)? - Yahoo Finance
GoodRx: The Tide Is Shifting Out Of This Company's Favor (Downgrade) (GDRX) - Seeking Alpha
Check out GoodRx Holdings's stock price (8GH-FF) in real time - CNBC
Can GoodRx Holdings Inc. stock attract ESG capital inflowsJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - Улправда
What Wall Street predicts for GoodRx Holdings Inc. stock priceWeekly Stock Summary & Daily Risk Controlled Trade Plans - DonanımHaber
Is GoodRx Holdings Inc. stock positioned for digital transformationJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - Bölüm Sonu Canavarı
GoodRx Holdings (GDRX): Morgan Stanley Lowers Price Target to $4 - GuruFocus
Will GoodRx Holdings Inc. stock benefit from commodity pricesJuly 2025 Short Interest & Smart Allocation Stock Reports - Улправда
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Hims & Hers Scales Technology-Driven Care as Profitability Evolves - TradingView — Track All Markets
GoodRx approves retention bonuses for CEO and CFO - MSN
GoodRx Approves Retention Bonuses for CEO and CFO - The Globe and Mail
[8-K] GoodRx Holdings, Inc. Reports Material Event | GDRX SEC FilingForm 8-K - Stock Titan
Why GoodRx (GDRX) Stock Is Trading Lower Today - Finviz
Barclays Initiates Coverage of GoodRx Holdings (GDRX) with Underweight Recommendation - Nasdaq
Barclays Initiates Coverage on GoodRx Holdings (GDRX) with Under - GuruFocus
What does Wall Street think about GoodRx Holdings (GDRX)? - MSN
What Does Wall Street Think About GoodRx Holdings (GDRX)? - Insider Monkey
Officer Nabiey Acquires 7,983 Of GoodRx Holdings Inc [GDRX] - TradingView — Track All Markets
Is GoodRx Holdings Inc a good long term investmentRelative Strength Index (RSI) & Free Tremendous Growth Opportunities - earlytimes.in
9 Best Affordable Stocks Under $5 to Buy for the Next 3 Years - Insider Monkey
Will GoodRx Holdings Inc. stock outperform value stocksJuly 2025 Market Mood & Risk Managed Investment Strategies - Newser
Why The Narrative Around GoodRx Is Shifting Amid New Partnerships And Industry Uncertainty - Yahoo Finance
Declining Stock and Decent Financials: Is The Market Wrong About GoodRx Holdings, Inc. (NASDAQ:GDRX)? - 富途牛牛
Will GoodRx Holdings Inc. stock deliver long term returnsPortfolio Profit Report & Community Supported Trade Ideas - Newser
GoodRx Holdings (GDRX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
GoodRx Reaches $32 Million Settlement in Info Sharing Class Suit - Bloomberg Law News
XTX Topco Ltd Boosts Stake in GoodRx Holdings, Inc. $GDRX - MarketBeat
HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? - sharewise.com
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.50%
2.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):